Cover Image
Read Now

Screening for Chlamydia trachomatis and Neisseria gonorrhoeae during pregnancy a health technology assessment

The purpose of this health technology assessment (HTA) is to conduct a systematic assessment of the clinical effectiveness, safety, cost-effectiveness, and perspectives and experiences of pregnant persons, partners, and health care providers regarding the screening of pregnant persons for Chlamydia...

Full description

Bibliographic Details
Main Author: Kanga, Ismat
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa CADTH 2018, November 2018
Series:CADTH health technology assessment report
Subjects:
Chlamydia Infections / Diagnosis
Canada
Infectious Disease Transmission, Vertical / Prevention & Control
Cost-benefit Analysis
Technology Assessment, Biomedical
Gonorrhea / Diagnosis
Treatment Outcome
Mass Screening / Economics
Prenatal Diagnosis / Economics
Pregnancy Complications, Infectious
Practice Guidelines As Topic
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The purpose of this health technology assessment (HTA) is to conduct a systematic assessment of the clinical effectiveness, safety, cost-effectiveness, and perspectives and experiences of pregnant persons, partners, and health care providers regarding the screening of pregnant persons for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) during pregnancy
Item Description:"PROSPERO Registration Number: CRD42018087016"
Physical Description:1 PDF file (181 pages) illustrations

Similar Items